Latest Insider Transactions at P Lx Pharma Inc. (PLXP)
This section provides a real-time view of insider transactions for P Lx Pharma Inc. (PLXP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PLx Pharma Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PLx Pharma Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2022
|
Rita M O'Connor Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
13,700
+21.26%
|
$41,100
$3.66 P/Share
|
|
Mar 15
2022
|
Natasha Giordano Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,100
+44.15%
|
$12,300
$3.65 P/Share
|
|
Jun 14
2021
|
Michael J Valentino Executive Chairman |
BUY
Open market or private purchase
|
Direct |
8,000
+0.18%
|
$96,000
$12.47 P/Share
|
|
Mar 05
2021
|
Michael J Valentino Executive Chairman |
BUY
Open market or private purchase
|
Direct |
25,000
+4.89%
|
$200,000
$8.0 P/Share
|
|
Dec 14
2020
|
John Hadden Director |
BUY
Open market or private purchase
|
Direct |
1,000
+12.6%
|
$5,000
$5.46 P/Share
|
|
Nov 25
2020
|
John Hadden Director |
BUY
Open market or private purchase
|
Direct |
500
+15.67%
|
$2,500
$5.48 P/Share
|
|
Nov 18
2020
|
Michael J Valentino Executive Chairman |
BUY
Open market or private purchase
|
Direct |
264,900
+36.46%
|
$794,700
$3.79 P/Share
|
|
Dec 27
2018
|
Park West Asset Management LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
397,495
+21.25%
|
$397,495
$1.0 P/Share
|